Silvia Pasquini - Search Results

Year	Number of Results
2016	2
2017	4
2018	3
2019	2
2020	7
2021	6
2022	9
2023	7
2024	2

1

Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence.

Bedini A, Elisi GM, Fanini F, Retini M, Scalvini L, Pasquini S, Contri C, Varani K, Spadoni G, Mor M, Vincenzi F, Rivara S. Bedini A, et al. Among authors: pasquini s. J Pineal Res. 2024 Mar;76(2):e12941. doi: 10.1111/jpi.12941. J Pineal Res. 2024. PMID: 38606814

2

A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients.

Rossi S, Tatangelo V, Dichiara M, Butini S, Gemma S, Brogi S, Pasquini S, Cappello M, Vincenzi F, Varani K, Lopresti L, Malchiodi M, Carrara C, Gozzetti A, Bocchia M, Marotta G, Patrussi L, Carullo G, Baldari CT, Campiani G. Rossi S, et al. Among authors: pasquini s. Biomed Pharmacother. 2024 May;174:116537. doi: 10.1016/j.biopha.2024.116537. Epub 2024 Apr 4. Biomed Pharmacother. 2024. PMID: 38579402 Free article.

3

2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A₁ Adenosine Receptor Positive Allosteric Modulators.

Oliva P, Suresh RR, Pasquini S, Salmaso V, Will EJ, Tosh DK, Gao ZG, Liu N, Gavrilova O, Vincenzi F, Varani K, Jacobson KA. Oliva P, et al. Among authors: pasquini s. ACS Med Chem Lett. 2023 Nov 13;14(12):1640-1646. doi: 10.1021/acsmedchemlett.3c00315. eCollection 2023 Dec 14. ACS Med Chem Lett. 2023. PMID: 38116442

4

Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy.

Fernandez M, Nigro M, Travagli A, Pasquini S, Vincenzi F, Varani K, Borea PA, Merighi S, Gessi S. Fernandez M, et al. Among authors: pasquini s. Pharmaceutics. 2023 Oct 10;15(10):2441. doi: 10.3390/pharmaceutics15102441. Pharmaceutics. 2023. PMID: 37896201 Free PMC article. Review.

5

Pharmacology of Adenosine Receptors: Recent Advancements.

Vincenzi F, Pasquini S, Contri C, Cappello M, Nigro M, Travagli A, Merighi S, Gessi S, Borea PA, Varani K. Vincenzi F, et al. Among authors: pasquini s. Biomolecules. 2023 Sep 14;13(9):1387. doi: 10.3390/biom13091387. Biomolecules. 2023. PMID: 37759787 Free PMC article. Review.

6

Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents.

Papa A, Cursaro I, Pozzetti L, Contri C, Cappello M, Pasquini S, Carullo G, Ramunno A, Gemma S, Varani K, Butini S, Campiani G, Vincenzi F. Papa A, et al. Among authors: pasquini s. Arch Pharm (Weinheim). 2023 Dec;356(12):e2300410. doi: 10.1002/ardp.202300410. Epub 2023 Sep 26. Arch Pharm (Weinheim). 2023. PMID: 37750286

7

Caffeine for Prevention of Alzheimer's Disease: Is the A_2A Adenosine Receptor Its Target?

Merighi S, Travagli A, Nigro M, Pasquini S, Cappello M, Contri C, Varani K, Vincenzi F, Borea PA, Gessi S. Merighi S, et al. Among authors: pasquini s. Biomolecules. 2023 Jun 8;13(6):967. doi: 10.3390/biom13060967. Biomolecules. 2023. PMID: 37371547 Free PMC article. Review.

8

Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors.

Gianferrara T, Pavan M, Bassani D, Vincenzi F, Pasquini S, Bolcato G, Varani K, Spalluto G, Federico S, Moro S. Gianferrara T, et al. Among authors: pasquini s. ChemMedChem. 2023 Jul 17;18(14):e202300109. doi: 10.1002/cmdc.202300109. Epub 2023 May 10. ChemMedChem. 2023. PMID: 37114338

9

Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions.

Papa A, Pasquini S, Galvani F, Cammarota M, Contri C, Carullo G, Gemma S, Ramunno A, Lamponi S, Gorelli B, Saponara S, Varani K, Mor M, Campiani G, Boscia F, Vincenzi F, Lodola A, Butini S. Papa A, et al. Among authors: pasquini s. Eur J Med Chem. 2023 Jan 15;246:114952. doi: 10.1016/j.ejmech.2022.114952. Epub 2022 Nov 25. Eur J Med Chem. 2023. PMID: 36462439

10

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications.

Pasquini S, Contri C, Cappello M, Borea PA, Varani K, Vincenzi F. Pasquini S, et al. Front Pharmacol. 2022 Oct 5;13:1030895. doi: 10.3389/fphar.2022.1030895. eCollection 2022. Front Pharmacol. 2022. PMID: 36278183 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year